Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

First-line chemotherapy of superficial bladder cancer: mitomycin vs thiotepa.

First-line chemotherapy of superficial bladder cancer: mitomycin vs thiotepa. Urology. 1985 Oct; 26(4 Suppl):27-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.